NCT00062374View on ClinicalTrials.gov

Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Gastric AdenocarcinomaStage II Gastric CancerStage III Gastric CancerStage IV Gastric Cancer
Interventions
DRUG

Cisplatin

Given IV

PROCEDURE

Computed Tomography

Undergo FDG and FLT PET/CT

RADIATION

Fludeoxyglucose F-18

Undergo FDG-PET/CT

OTHER

Fluorothymidine F-18

Undergo FLT-PET/CT

DRUG

Irinotecan Hydrochloride

Given IV

PROCEDURE

Positron Emission Tomography

Undergo FDG and FLT PET/CT

PROCEDURE

Therapeutic Conventional Surgery

Undergo radical subtotal or total gastrectomy with lymph node dissection

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00062374 - Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction | Biotech Hunter | Biotech Hunter